31.3. Analysis.
Comparison 31 NRD‐101 (Suvenyl) versus placebo (saline plus oral placebo), Outcome 3 Patient global assessment (0‐100 mm VAS) change between baseline and 45 to 52 weeks post‐injection.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.